Stephen Edberg became emeritus at Yale in three departments: Laboratory Medicine, Internal Medicine, and Chemical Engineering. He is currently on the Adjunct Faculty in the Department of Pathology at the Mt. Sinai School of Medicine in New York City. Dr. Edberg is the Founder and Chief Scientist at the biotechnology firm Pilots Point LLC (www.pilotspoint.net) where he developed an inexpensive series of tests for antibiotic resistant bacteria including CRE (carbapenams); ciprofloxicin; MRSA; VISA; all S. aureus; and VRE. Dr. Edberg also developed an inexpensive instrument for these. The tests and instrument are CE/IVD in Europe and waived by the FDA in the U.S. Dr. Edberg continues to publish in peer reviewed journals and has 17 patents. He lives with his artist wife Cathy in Westbrook, CT and in Manhattan.
Education and Training: SUNY at Buffalo (1971), Ph.D. University of Washington, Fellow
Honors and Recognition: BD Award for Lifetime Achievement in Clinical Microbiology, American Society for Microbiology (2008)